| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.1M | -40.6% |
| Cost of Revenue | $1.7M | +33.1% |
| R&D Expense | $140.7M | -2.2% |
| SG&A Expense | $65.5M | +24.3% |
| Operating Income | -$185.3M | -0.6% |
| Pre-tax Income | -$193.3M | +18.5% |
| Income Tax | $5.6M | +131.8% |
| Net Income | -$199.0M | +16.9% |
| EPS (Basic) | -$3.46 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.2M | -49.5% |
| Current Assets | $656.0M | +68.1% |
| Total Assets | $824.9M | +48.2% |
| Current Liabilities | $62.9M | +57.1% |
| Long-term Debt | $71.9M | +8.9% |
| Total Liabilities | $626.0M | +11.1% |
| Stockholders' Equity | $198.9M | +3045.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$178.0M | +2.6% |
| Capital Expenditures | $439K | -87.0% |
| Investing Cash Flow | -$321.6M | -297.4% |
| Financing Cash Flow | $415.4M | +798.3% |
| Free Cash Flow | -$178.4M | +4.1% |
| +29.7% |
| EPS (Diluted) | -$3.46 | +29.7% |